Telehealth platform tackles the menopause care gap by offering nationwide access to doctor-prescribed bioidentical hormone therapy
Austin, Texas — May 19, 2025 —(BioSpace) More than 50 million women in the United States are currently navigating menopause, yet many still struggle to find comprehensive, evidence-based care. Winona, a telehealth company operating in more than 40 states, is working to close that gap by connecting women nationwide with physician-guided, personalized bioidentical hormone replacement therapy (HRT).
Menopause is not a single event but an extended health transition with physical, emotional, and cognitive effects that can span years. From hot flashes to anxiety, and from insomnia to weight changes, many women go without adequate support simply because specialized menopause care isn't accessible where they live. Despite growing evidence supporting its use, HRT remains underused — often held back by outdated stigma and everyday logistical barriers rather than medical appropriateness.
Dr. Cathleen Brown, a board-certified OB/GYN and Medical Director at Winona, has seen firsthand how many women are told that symptoms such as hot flashes, weight gain, low libido, anxiety, and painful sex are simply “normal” and must be endured rather than treated. In her view, menopause doesn't have to be a setback; with the right support, it can be a turning point that pushes women to prioritize their health and well-being.
Winona's platform allows women to complete a medical evaluation, consult with a licensed U.S. physician, and receive a bioidentical HRT prescription tailored to their individual hormonal needs — entirely online.
The company's approach extends beyond prescriptions. Through its online medical journal, Winona publishes free, evidence-based articles designed to explain common myths, translate current research, and give women information many find their doctors don't have time to cover.